Dr Melanie Oates

Research Grants

PETReA: Phase 3 Evaluation of PET-guided, Response-Adapted Therapy in Patients with Previously Untreated, High Tumour Burden Follicular Lymphoma

ROCHE PRODUCTS LTD (UK)

March 2020 - March 2028

Serial measurement of the subclinical leukaemic burden as an early biomarker for overt relapse in chronic lymphocytic leukaemia

CANCER RESEARCH UK (UK)

March 2014 - March 2021